相似文献
1
The very stable lentiviral vector.
Mol Ther Methods Clin Dev. 2024 Mar 5;32(1):101223. doi: 10.1016/j.omtm.2024.101223. eCollection 2024 Mar 14.
2
Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2988-93. doi: 10.1073/pnas.96.6.2988.
3
[Construction of a recombinant lentiviral vector of p38 MAPK and establishment of a human prostatic carcinoma cell line stably expressing p38 MAPK].
Nan Fang Yi Ke Da Xue Xue Bao. 2012 Mar;32(3):317-21.
4
[Transfection of HL-60 cells by Venus lentiviral vector].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):576-80. doi: 10.7534/j.issn.1009-2137.2013.03.008.
5
Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.
Cancer Res. 2002 Nov 1;62(21):6099-107.
6
Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
J Gene Med. 2007 Sep;9(9):743-50. doi: 10.1002/jgm.1078.
7
A lentiviral vector bearing a reverse intron demonstrates superior expression of both proteins and microRNAs.
RNA Biol. 2017 Nov 2;14(11):1570-1579. doi: 10.1080/15476286.2017.1334755. Epub 2017 Jul 21.
8
[Construction and identification of ha1 recombinant lentiviral vector].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Dec;18(6):1609-12.
9
Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses.
J Gene Med. 2004 Nov;6(11):1197-205. doi: 10.1002/jgm.623.
10
[Construction of recombinant porcine transforming growth factor beta1 gene lentiviral vector and its expression in bone marrow mesenchymal stem cells].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Jul;26(7):849-54.
本文引用的文献
1
Long-term stability of clinical-grade lentiviral vectors for cell therapy.
Mol Ther Methods Clin Dev. 2024 Jan 10;32(1):101186. doi: 10.1016/j.omtm.2024.101186. eCollection 2024 Mar 14.
2
Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering.
J Immunother Cancer. 2023 Mar;11(3). doi: 10.1136/jitc-2022-006292.
3
Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions.
Annu Rev Chem Biomol Eng. 2022 Jun 10;13:141-165. doi: 10.1146/annurev-chembioeng-092220-125832. Epub 2022 Mar 17.
4
Lentiviral Vector Bioprocessing.
Viruses. 2021 Feb 9;13(2):268. doi: 10.3390/v13020268.
5
Restriction of HIV-1 and other retroviruses by TRIM5.
Nat Rev Microbiol. 2019 Sep;17(9):546-556. doi: 10.1038/s41579-019-0225-2. Epub 2019 Jul 16.
6
Clinical use of lentiviral vectors.
Leukemia. 2018 Jul;32(7):1529-1541. doi: 10.1038/s41375-018-0106-0. Epub 2018 Mar 22.
7
Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients.
Mol Ther. 2018 Jan 3;26(1):269-279. doi: 10.1016/j.ymthe.2017.10.012. Epub 2017 Oct 20.
8
Gene transfer in humans using a conditionally replicating lentiviral vector.
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17372-7. doi: 10.1073/pnas.0608138103. Epub 2006 Nov 7.
Zotero 插件